To amend the Controlled Substances Act to clarify how controlled substance analogues that are imported or offered for import are to be regulated, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To amend the Controlled Substances Act to clarify how controlled substance analogues that are imported or offered for import are to be regulated, and for other purposes., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Trade, Criminal Justice.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H26E1AF1FBFEA488E842A9F77A42E12D4: 1. Short title; table of contents This Act may be cited as the Stop the Importation and Manufacturing of Synthetic Analogues Act of 2024 or the SIMSA Act of...
- Section HCC42D9ED0E604BC3B18B5E64907C47A1: 2. Establishment of Schedule A Section 202 of the Controlled Substances Act (21 U.S.C. 812) is amended— in subsection (a), by striking five schedules of...
- Section H2409C7D87AF04A2A991F16ADDC8F1650: Schedule A Any substance temporarily or permanently scheduled by the Attorney General in accordance with section 201(k).
- Section H6BB061D622AD4A388C60D88BAF55326E: 3. Temporary and permanent scheduling of schedule A substances Section 201 of the Controlled Substances Act (21 U.S.C. 811) is amended by adding at the end the...
- Section HA338E8D1232547B09DE33539172218EF: 4. Penalties Section 1010 of the Controlled Substances Import and Export Act (21 U.S.C. 960) is amended— in subsection (a), by inserting or a drug or substance...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To amend the Controlled Substances Act to clarify how controlled substance analogues that are imported or offered for import are to be regulated, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Trade, Criminal Justice
Primary Purpose
This bill, To amend the Controlled Substances Act to clarify how controlled substance analogues that are imported or offered for import are to be regulated, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
IntroducedMr. Grassley (for himself, Ms. Hassan, Ms. Ernst, Mrs. Shaheen, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology